Citigroup’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $298K | Sell |
26,230
-48,390
| -65% | -$549K | ﹤0.01% | 3171 |
|
2025
Q1 | $496K | Buy |
74,620
+16,487
| +28% | +$110K | ﹤0.01% | 2949 |
|
2024
Q4 | $641K | Buy |
58,133
+32,467
| +126% | +$358K | ﹤0.01% | 2862 |
|
2024
Q3 | $315K | Buy |
25,666
+10,522
| +69% | +$129K | ﹤0.01% | 3292 |
|
2024
Q2 | $205K | Buy |
15,144
+9,678
| +177% | +$131K | ﹤0.01% | 3144 |
|
2024
Q1 | $73.8K | Buy |
5,466
+1,494
| +38% | +$20.2K | ﹤0.01% | 3693 |
|
2023
Q4 | $20.9K | Buy |
3,972
+3,372
| +562% | +$17.7K | ﹤0.01% | 4221 |
|
2023
Q3 | $2.36K | Sell |
600
-8,868
| -94% | -$34.9K | ﹤0.01% | 4168 |
|
2023
Q2 | $101K | Buy |
9,468
+8,623
| +1,020% | +$91.7K | ﹤0.01% | 3578 |
|
2023
Q1 | $7.04K | Sell |
845
-197
| -19% | -$1.64K | ﹤0.01% | 4178 |
|
2022
Q4 | $9.62K | Sell |
1,042
-152
| -13% | -$1.4K | ﹤0.01% | 4144 |
|
2022
Q3 | $15K | Sell |
1,194
-1,434
| -55% | -$18K | ﹤0.01% | 4127 |
|
2022
Q2 | $35K | Sell |
2,628
-17,932
| -87% | -$239K | ﹤0.01% | 4010 |
|
2022
Q1 | $433K | Sell |
20,560
-34,234
| -62% | -$721K | ﹤0.01% | 2946 |
|
2021
Q4 | $1.32M | Buy |
54,794
+14,927
| +37% | +$358K | ﹤0.01% | 2291 |
|
2021
Q3 | $1.01M | Sell |
39,867
-28,749
| -42% | -$731K | ﹤0.01% | 2384 |
|
2021
Q2 | $2.31M | Buy |
68,616
+24,679
| +56% | +$831K | ﹤0.01% | 1999 |
|
2021
Q1 | $1.71M | Buy |
43,937
+40,015
| +1,020% | +$1.55M | ﹤0.01% | 2028 |
|
2020
Q4 | $243K | Buy |
3,922
+1,076
| +38% | +$66.7K | ﹤0.01% | 3126 |
|
2020
Q3 | $95K | Sell |
2,846
-2,900
| -50% | -$96.8K | ﹤0.01% | 3170 |
|
2020
Q2 | $137K | Sell |
5,746
-1,446
| -20% | -$34.5K | ﹤0.01% | 3273 |
|
2020
Q1 | $165K | Buy |
7,192
+2,800
| +64% | +$64.2K | ﹤0.01% | 2976 |
|
2019
Q4 | $124K | Buy |
4,392
+3,985
| +979% | +$113K | ﹤0.01% | 3398 |
|
2019
Q3 | $9K | Buy |
+407
| New | +$9K | ﹤0.01% | 4624 |
|